跳至主要内容
临床试验/NCT00120432
NCT00120432已完成3 期

Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation

Khon Kaen University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2004年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
80
试验地点
1
主要终点
horizontal pupil diameter

研究概览

简要总结

The purpose of this study is to compare the efficacy on pupillary dilation between the single dose versus the three doses of 1% tropicamide with 10% phenylephrine for complete ocular examination.

详细描述

To the best of the authors' knowledge, there have been no clinical trials using an appropriate regimen for pupillary dilation up until now. Therefore, the authors were interested to find out the most appropriate regimen for complete ocular examination, based on the finding that a pupil diameter of 6 mm or greater is adequate for indirect ophthalmoscopy. The authors hypothesize that a single dose of 1% tropicamide and 10% phenylephrine is adequate to complete the job and are conducting this prospective randomized clinical controlled trial to prove the hypothesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged between 20 and 80 years old
  • dark iris
  • require binocular indirect ophthalmoscopy for complete ocular examination
  • signed written consent forms

排除标准

  • history of ocular trauma
  • history of intraocular surgery
  • history of laser treatment
  • previous eye drop instillation that may affect pupillary dilation
  • ocular diseases that may affect pupil size such as Horner's syndrome, Adies' pupil, glaucoma and uveitis
  • history of diabetes mellitus, severe hypertension and cardiovascular diseases

研究组 & 干预措施

A

Active Comparator

single dose vs three doses of 1%tropicamide and 10%phenylephrine

干预措施: 1% tropicamide and 10% phenylephrine (Drug)

结局指标

主要结局

horizontal pupil diameter

时间窗: 30 min

次要结局

  • systolic blood pressure(30 min)
  • diastolic blood pressure(30 min)
  • heart rate(30 min)
  • adverse drug reaction(30 min)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yosanan Yospaiboon

Professor

Khon Kaen University

研究点 (1)

Loading locations...

相似试验